Cargando…
Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
Background: The susceptibility of breast cancer is largely affected by the metabolic capacity of breast tissue. This ability depends in part on the expression profile of cytochrome P450 (CYPs). CYPs are a superfamily of enzymes with related catalysis to endogenous and exogenous bioactive substances,...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419690/ https://www.ncbi.nlm.nih.gov/pubmed/32850442 http://dx.doi.org/10.3389/fonc.2020.01379 |